| Specialty | Glaucoma |
| Medical School | Harvard Medical School |
| Residency | University of California, San Francisco |
| Fellowship | University of California, San Francisco |
| Special Interest | Glaucoma Surgery, Optic neuropathy and aging of the eye, Cell and molecular biology of uveoscleral outflow, Imaging of the optic disc and retinal nerve fiber layer, Mechanisms of optic nerve damage in glaucoma, Neuroprotection in glaucoma, Measurement of intraocular pressure, Drug delivery to eye, Cataract Surgery |
| Publications | View on PubMed |
Biography available in Chinese and Spanish.
Robert N. Weinreb, M.D. is the Chair and Distinguished Professor of the Viterbi Family Department of Ophthalmology at the University of California, San Diego as well as Director of the Shiley Eye Institute. He is also a Distinguished Professor in Bioengineering. Dr. Weinreb graduated from Harvard Medical School (M.D.) and the Massachusetts Institute of Technology (Electrical Engineering).
A clinician, a surgeon and scientist, he oversees the clinical activities and vision research at the Shiley Eye Institute and within the Department of Ophthalmology. Patients from throughout the world seek his diagnostic and surgical skill.
Dr. Weinreb’s clinical and research interests are diverse and range from the front of the eye to the back of the eye. They include ocular imaging, neuroprotection of glaucoma, application of artificial intelligence to healthcare from the eye, and both glaucoma and cataract surgery.
He has served the most prestigious organizations in Ophthalmology as President of the Association for Research in Vision and Ophthalmology, President of the World Glaucoma Association, President of the American Glaucoma Society, President of the American Glaucoma Society Foundation and President of the Pan American Glaucoma Society.
The recipient of numerous awards, recently including the Laureate Award from the World Glaucoma Association, Bietti Medal of the International Council of Ophthalmology, Watson Medal of the University of Cambridge (England) and the Innovators Award of the American Glaucoma Society. He was elected to The Ophthalmologist Hall of Fame and has been awarded honorary membership in several national societies, including the Societe Francaise D’Ophthalmologie.
Dr. Weinreb has delivered more than 180 named lectures and serves on several Editorial Boards, including International Glaucoma Review (Chief Editor) and Investigative Ophthalmology and Visual Science. He has trained more than 170 post-doctoral Fellows in Glaucoma, including 22 department Chairs and many others who hold distinguished positions in academia and industry in the United States and throughout the world.
His h factor in May 2025 was 156, the highest in world Glaucoma, and his research has ~100,000 citations. He also has been cited for several consecutive years by Expertscape as the #1 expert in world glaucoma for impact and quality of his contributions, and by The Ophthalmologist as #2 for influence in world ophthalmology on their prestigious Power List.
The information contained in this online site is intended to provide accurate and helpful health information for the general public. It is made available with the understanding that the author and publisher are not engaged in rendering medical, health, psychological, or any other kind of personal professional services on this site. The information should not be considered complete and does not cover all diseases, ailments, physical conditions or their treatment. It should not be used in place of a call or visit to a medical, health or other competent professional, who should be consulted before adopting any of the suggestions in this site or drawing inferences from it.
The information about drugs contained on this site is general in nature. It does not cover all possible uses, actions, precautions, side effects, or interactions of the medicines mentioned, nor is the information intended as medical advice for individual problems or for making an evaluation as to the risks and benefits of taking a particular drug.
The operator(s) of this site, and the publisher, specifically disclaim all responsibility for any liability, loss or risk, personal or otherwise, which is incurred as a consequence, directly or indirectly, of the use and application of any of the material on this site.
Click Here To Accept